NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 324 filers reported holding NATERA INC in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,638 | -11.1% | 263 | -2.2% | 0.00% | 0.0% |
Q2 2023 | $13,090 | -12.4% | 269 | 0.0% | 0.00% | -33.3% |
Q1 2023 | $14,935 | +41.4% | 269 | +2.3% | 0.00% | +50.0% |
Q4 2022 | $10,565 | +111.3% | 263 | +117.4% | 0.00% | +100.0% |
Q3 2022 | $5,000 | +400.0% | 121 | +365.4% | 0.00% | – |
Q2 2022 | $1,000 | -92.3% | 26 | -91.7% | 0.00% | -100.0% |
Q1 2022 | $13,000 | +550.0% | 314 | +1644.4% | 0.00% | – |
Q4 2021 | $2,000 | -84.6% | 18 | -84.7% | 0.00% | -100.0% |
Q3 2021 | $13,000 | +1200.0% | 118 | +883.3% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 12 | +33.3% | 0.00% | – |
Q1 2021 | $1,000 | -50.0% | 9 | -43.8% | 0.00% | – |
Q4 2020 | $2,000 | +100.0% | 16 | +100.0% | 0.00% | – |
Q3 2020 | $1,000 | – | 8 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 8 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 8 | -57.9% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | – | 19 | +90.0% | 0.00% | – |
Q2 2019 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,100,560 | $314,831,000 | 18.93% |
Blue Water Life Science Advisors, LP | 328,836 | $33,390,000 | 16.31% |
Foresite Capital Management III, LLC | 127,305 | $12,927,000 | 11.35% |
HWG Holdings LP | 148,794 | $15,109,000 | 7.53% |
Eagle Health Investments LP | 168,394 | $17,099,000 | 6.71% |
Lagoda Investment Management, L.P. | 103,325 | $10,492,000 | 5.24% |
Ally Bridge Group (NY) LLC | 218,000 | $22,136,000 | 4.24% |
PERKINS CAPITAL MANAGEMENT INC | 63,950 | $6,493,000 | 3.76% |
BRIDGER MANAGEMENT, LLC | 388,620 | $39,460,000 | 3.68% |
Hudson Executive Capital LP | 527,086 | $53,520,000 | 3.32% |